QuantumSi Competitors
| QSI Stock | USD 1.13 0.04 3.42% |
QuantumSi vs ADC Therapeutics Correlation
Very weak diversification
The correlation between QuantumSi and ADCT is 0.59 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding QuantumSi and ADCT in the same portfolio, assuming nothing else is changed.
Moving together with QuantumSi Stock
| 0.77 | EVGN | Evogene | PairCorr |
| 0.79 | IMNN | Imunon Inc | PairCorr |
| 0.7 | IPHA | Innate Pharma | PairCorr |
| 0.82 | LYRA | Lyra Therapeutics | PairCorr |
| 0.86 | MBIO | Mustang Bio | PairCorr |
Moving against QuantumSi Stock
| 0.64 | ARWR | Arrowhead Pharmaceuticals | PairCorr |
| 0.54 | MRKR | Marker Therapeutics | PairCorr |
| 0.52 | MOLN | Molecular Partners | PairCorr |
| 0.43 | CING | Cingulate | PairCorr |
| 0.36 | AEON | AEON Biopharma | PairCorr |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of QuantumSi's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
QuantumSi Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between QuantumSi and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of QuantumSi and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of QuantumSi does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between QuantumSi Stock performing well and QuantumSi Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze QuantumSi's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SLDB | 3.67 | 0.19 | 0.05 | 0.14 | 4.40 | 11.36 | 21.63 | |||
| AURA | 2.38 | (0.14) | 0.00 | (0.05) | 0.00 | 4.74 | 18.08 | |||
| AUTL | 4.04 | (0.22) | 0.00 | (0.07) | 0.00 | 10.45 | 30.76 | |||
| RCKT | 2.92 | (0.18) | 0.00 | (0.09) | 0.00 | 8.04 | 16.20 | |||
| LBRX | 3.76 | 0.52 | 0.11 | (0.64) | 3.67 | 9.38 | 23.59 | |||
| ANNX | 4.24 | 1.00 | 0.24 | 6.88 | 3.42 | 11.30 | 35.10 | |||
| ALT | 4.01 | 0.60 | 0.10 | 0.70 | 5.09 | 9.80 | 33.75 | |||
| ENGN | 4.55 | 0.44 | 0.10 | 0.20 | 4.62 | 11.36 | 61.40 | |||
| DBVT | 4.25 | 0.67 | 0.14 | (0.66) | 4.01 | 10.53 | 36.36 | |||
| ADCT | 3.26 | (0.20) | 0.00 | (0.18) | 0.00 | 8.49 | 22.84 |
Cross Equities Net Income Analysis
Compare QuantumSi and related stocks such as Solid Biosciences LLC, Aura Biosciences, and Autolus Therapeutics Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SLDB | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (6.4 M) | (21.5 M) | (52.1 M) | (74.8 M) | (117.2 M) | (88.3 M) | (72.2 M) | (86 M) | (96 M) | (124.7 M) | (112.2 M) | (117.8 M) |
| AURA | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (24.2 M) | (22.2 M) | (35.3 M) | (58.8 M) | (76.4 M) | (86.9 M) | (78.2 M) | (82.1 M) |
| AUTL | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (7.5 M) | (12.6 M) | (19.7 M) | (31.1 M) | (123.8 M) | (142.1 M) | (142.1 M) | (148.8 M) | (208.4 M) | (220.7 M) | (198.6 M) | (188.7 M) |
| RCKT | (6.1 M) | (6.1 M) | (6.1 M) | (7.6 M) | (9.5 M) | (68 M) | (42.9 M) | (29.5 M) | (74.5 M) | (83.2 M) | (146.7 M) | (169.1 M) | (221.9 M) | (245.6 M) | (258.7 M) | (232.9 M) | (221.2 M) |
| LBRX | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (14.3 M) | (6.3 M) | (63.1 M) | (56.8 M) | (54 M) |
| ANNX | (18.7 M) | (18.7 M) | (18.7 M) | (18.7 M) | (18.7 M) | (18.7 M) | (18.7 M) | (18.7 M) | (18.3 M) | (37.2 M) | (62.7 M) | (127.8 M) | (138.3 M) | (134.2 M) | (138.2 M) | (124.4 M) | (130.6 M) |
| ALT | 277.3 K | (3.8 M) | (4.9 M) | (11.7 M) | (10 M) | (3.4 M) | 193.9 M | (46.4 M) | (39.2 M) | (20.5 M) | (49 M) | (97.1 M) | (84.7 M) | (88.4 M) | (95.1 M) | (85.6 M) | (81.3 M) |
| DBVT | (6.1 M) | (9.4 M) | (17 M) | (26.6 M) | (29.1 M) | (48.5 M) | (126.3 M) | (177.2 M) | (190.3 M) | (172 M) | (159.6 M) | (97.8 M) | (96.3 M) | (72.7 M) | (113.7 M) | (102.3 M) | (107.5 M) |
| ADCT | (89.9 M) | (89.9 M) | (89.9 M) | (89.9 M) | (89.9 M) | (89.9 M) | (89.9 M) | (89.9 M) | (123.1 M) | (116.5 M) | (246.3 M) | (230 M) | (157.1 M) | (240.1 M) | (157.8 M) | (142.1 M) | (149.2 M) |
QuantumSi and related stocks such as Solid Biosciences LLC, Aura Biosciences, and Autolus Therapeutics Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in QuantumSi financial statement analysis. It represents the amount of money remaining after all of QuantumSi operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.QuantumSi Competitive Analysis
The better you understand QuantumSi competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, QuantumSi's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across QuantumSi's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
QuantumSi Competition Performance Charts
Five steps to successful analysis of QuantumSi Competition
QuantumSi's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by QuantumSi in relation to its competition. QuantumSi's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of QuantumSi in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact QuantumSi's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to QuantumSi, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your QuantumSi position
In addition to having QuantumSi in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Conservative Funds Thematic Idea Now
Conservative Funds
Funds or Etfs that invest using buy-and-hold investment strategy in companies with consistent growth over many years of operation. The Conservative Funds theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Conservative Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out QuantumSi Correlation with its peers. For more detail on how to invest in QuantumSi Stock please use our How to Invest in QuantumSi guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is there potential for Biotechnology market expansion? Will QuantumSi introduce new products? Factors like these will boost the valuation of QuantumSi. Anticipated expansion of QuantumSi directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about QuantumSi listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.67) | Revenue Per Share | Quarterly Revenue Growth (0.30) | Return On Assets | Return On Equity |
Investors evaluate QuantumSi using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating QuantumSi's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause QuantumSi's market price to deviate significantly from intrinsic value.
It's important to distinguish between QuantumSi's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding QuantumSi should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, QuantumSi's market price signifies the transaction level at which participants voluntarily complete trades.